Giulia Micoli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Giulia Micoli has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Jaana Oikkonen
Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
58 shared publications - Sampsa Hautaniemi
Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
58 shared publications - Johanna Hynninen
Department of Obstetrics and Gynecology, University of Turku and Turku University Hospital, Turku, Finland
57 shared publications - Taru Annika Muranen
Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
57 shared publications - Kari Lavikka
Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
56 shared publications - Yilin Li
Research Program in Systems Oncology, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland
56 shared publications
Latest Publications
- Open Access
- 8 August 2026
- Published by Elsevier in International Journal of Gynecological Cancer
Biological features associated with poor response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma
- 8 August 2026
- Published by Elsevier in International Journal of Gynecological Cancer
Open AccessBiological features associated with poor response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma
- Open Access
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian Cancer
Identification and functional validation of inactivating mutation on a source RC-L1
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian Cancer
Identification and functional validation of inactivating mutation on a source RC-L1
- Open Access
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian Cancer
Catalog and Characteristics of L1 insertions identified by LDI-PCR/Nanopore-seq
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian Cancer
Catalog and Characteristics of L1 insertions identified by LDI-PCR/Nanopore-seq
- Open Access
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian Cancer
Association of L1 status of HGSC patients with their genomic features
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S7 from Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian Cancer
Association of L1 status of HGSC patients with their genomic features
- Open Access
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian Cancer
Primers and reaction conditions for Genotyping PCR
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian Cancer
Primers and reaction conditions for Genotyping PCR
- Open Access
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian Cancer
Agarose gel image showcasing results of source RC-L1s genotyping PCR
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian Cancer
Agarose gel image showcasing results of source RC-L1s genotyping PCR
- Open Access
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S8 from Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian Cancer
Within-patient variability in L1 profiles
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S8 from Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian Cancer
Within-patient variability in L1 profiles
- Open Access
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S9 from Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian Cancer
PCR validation of de novo L1 insertions identified by LDI-PCR/Nanopore-seq
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S9 from Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian Cancer
PCR validation of de novo L1 insertions identified by LDI-PCR/Nanopore-seq
- Open Access
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian Cancer
Agarose gel image showcasing results of Long-distance Inverse PCR (LDI-PCR) to detect de novo L1 retrotransposition in HGSC tumors
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian Cancer
Agarose gel image showcasing results of Long-distance Inverse PCR (LDI-PCR) to detect de novo L1 retrotransposition in HGSC tumors
- Open Access
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S8 from Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian Cancer
Association of L1 burden with clinical and lifestyle factors of HGSC patients
- 19 February 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S8 from Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian Cancer
Association of L1 burden with clinical and lifestyle factors of HGSC patients